Author

Laura Lahtinen

Observed names: L Lahtinen, L. Lahtinen, LAURA I. LAHTINEN

Institutions: Central Finland Health Care District, University of Jyväskylä

Observed institutions: University of Eastern Finland, Kuopio University Hospital, Central Finland Health Care District, University of Jyväskylä

ORCID: 0000-0001-7559-2168

Observed ORCID: 0000-0001-7559-2168

OpenAlex ID: A5065878860

Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer

2015 · T T Seppälä, J P Böhm, et al. · British Journal of Cancer · 165

BRAF mutation in sporadic colorectal cancer and Lynch syndrome

2013 · Alexandra Thiel, Mira Heinonen, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 93

Epidemiological, clinical and molecular characterization of Lynch‐like syndrome: A population‐based study

2018 · Noora Porkka, Laura Lahtinen, et al. · International Journal of Cancer · 45

Increased expression and activity of urokinase‐type plasminogen activator during epileptogenesis

2006 · Laura Lahtinen, Katarzyna Lukasiuk, et al. · European Journal of Neuroscience · 36

Expression of urokinase-type plasminogen activator receptor is increased during epileptogenesis in the rat hippocampus

2009 · L. Lahtinen, N. Huusko, et al. · Neuroscience · 33

Urokinase-type plasminogen activator deficiency has little effect on seizure susceptibility and acquired epilepsy phenotype but reduces spontaneous exploration in mice

2014 · J. Rantala, S. Kemppainen, et al. · Epilepsy & Behavior · 21

Urokinase-type plasminogen activator regulates neurodegeneration and neurogenesis but not vascular changes in the mouse hippocampus after status epilepticus

2009 · Laura Lahtinen, Xavier Ekolle Ndode-Ekane, et al. · Neurobiology of Disease · 18

NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study

2024 · Sonja Boyd, Taru Mustamäki, et al. · Hepatology Communications · 11

Systemic circulating microRNA landscape in Lynch syndrome

2022 · Tero Sievänen, Tia‐Marje Korhonen, et al. · International Journal of Cancer · 9

Clonal Evolution of MEK/MAPK Pathway Activating Mutations in a Metastatic Colorectal Cancer Case

2019 · KAISA I. LEHTOMAKI, LAURA I. LAHTINEN, et al. · Anticancer Research · 9

Detection of a major Lynch Syndrome-causing MLH1 founder variant in a large-scale genotyped cohort

2024 · Lauri J. Sipilä, Mervi Aavikko, et al. · Familial Cancer · 8

EGFR gene copy number decreases during anti-EGFR antibody therapy in colorectal cancer

2018 · Eva-Maria Birkman, Tuulia Avoranta, et al. · Human Pathology · 4

Corrigendum to “Urokinase-type plasminogen activator regulates neurodegeneration and neurogenesis but not vascular changes in the mouse hippocampus after status epilepticus” [Neurobiol. Dis. 37/3 (2010) 692–703]

2010 · Laura Lahtinen, Xavier Ekolle Ndode-Ekane, et al. · Neurobiology of Disease · 2

Molecular Profiling of Epileptogenesis: Expression and Function of Urokinase-type Plasminogen Activator and Its Receptor During Epileptogenesis

2010 · Laura Lahtinen · UEF eRepo (University of Eastern Finland)

Works count: 14

Citation count: 454

H-index: 9

I10-index: 8